The molecular regulation of arteriovenous specification and maintenance
- 26 February 2015
- journal article
- review article
- Published by Wiley in Developmental Dynamics
- Vol. 244 (3), 391-409
- https://doi.org/10.1002/dvdy.24252
Abstract
The formation of a hierarchical vascular network, composed of arteries, veins, and capillaries, is essential for embryogenesis and is required for the production of new functional vasculature in the adult. Elucidating the molecular mechanisms that orchestrate the differentiation of vascular endothelial cells into arterial and venous cell fates is requisite for regenerative medicine, as the directed formation of perfused vessels is desirable in a myriad of pathological settings, such as in diabetes and following myocardial infarction. Additionally, this knowledge will enhance our understanding and treatment of vascular anomalies, such as arteriovenous malformations (AVMs). From studies in vertebrate model organisms, such as mouse, zebrafish, and chick, a number of key signaling pathways have been elucidated that are required for the establishment and maintenance of arterial and venous fates. These include the Hedgehog, Vascular Endothelial Growth Factor (VEGF), Transforming Growth Factor‐β (TGF‐β), Wnt, and Notch signaling pathways. In addition, a variety of transcription factor families acting downstream of, or in concert with, these signaling networks play vital roles in arteriovenous (AV) specification. These include Notch and Notch‐regulated transcription factors (e.g., HEY and HES), SOX factors, Forkhead factors, β‐Catenin, ETS factors, and COUP‐TFII. It is becoming apparent that AV specification is a highly coordinated process that involves the intersection and carefully orchestrated activity of multiple signaling cascades and transcriptional networks. This review will summarize the molecular mechanisms that are involved in the acquisition and maintenance of AV fate, and will highlight some of the limitations in our current knowledge of the molecular machinery that directs AV morphogenesis. Developmental Dynamics 244:391–409, 2015.Keywords
Funding Information
- American Heart Association (SDG12060353)
- Canadian Cancer Society (702835)
- Canadian Institutes of Health Research (MOP-119506)
- Canadian Institutes of Health Research (MTA-118968)
This publication has 222 references indexed in Scilit:
- Efficient Direct Reprogramming of Mature Amniotic Cells into Endothelial Cells by ETS Factors and TGFβ SuppressionCell, 2012
- Stepwise arteriovenous fate acquisition during mammalian vasculogenesisDevelopmental Dynamics, 2011
- Fate Restriction in the Growing and Regenerating Zebrafish FinDevelopmental Cell, 2011
- The contribution of the Tie2+ lineage to primitive and definitive hematopoietic cellsgenesis, 2010
- VEGF Induces More Severe Cerebrovascular Dysplasia in Eng+/− than in Alk1+/− MiceTranslational Stroke Research, 2010
- Notch1 activation in mice causes arteriovenous malformations phenocopied by ephrinB2 and EphB4 mutantsgenesis, 2010
- The Canonical Notch Signaling Pathway: Unfolding the Activation MechanismCell, 2009
- Combinatorial Regulation of Endothelial Gene Expression by Ets and Forkhead Transcription FactorsCell, 2008
- Sox17 Dependence Distinguishes the Transcriptional Regulation of Fetal from Adult Hematopoietic Stem CellsCell, 2007
- Control of cell fate and differentiation by Sry-related high-mobility-group box (Sox) transcription factorsThe International Journal of Biochemistry & Cell Biology, 2007